查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1579292

女性健康診斷藥物市場：按類型、應用和最終用戶分類 - 全球預測 2025-2030

Women's Health Diagnostics Market by Type (Point-of-Care, Self Check), Application (Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年女性健康診斷市場價值為433.6億美元，預計到2024年將達到468.2億美元，複合年成長率為9.25%，到2030年將達到805.9億美元。

女性健康診斷市場專注於診斷工具和技術，旨在檢測和管理女性特有或不成比例的健康狀況，例如乳癌、骨質疏鬆症和生殖健康問題，這是醫療保健中至關重要的部分。對此類診斷的需求源於對及時、準確檢測的需求，這對於有效治療和管理此類疾病至關重要。應用包括早期癌症檢測、產前檢測、不孕症診斷和一般健康監測。最終用途包括醫院、診斷實驗室、居家醫療和專門從事婦女健康的專科診所。

主要市場統計
基準年[2023] 433.6億美元
預測年份 [2024] 468.2億美元
預測年份 [2030] 805.9億美元
複合年成長率（%） 9.25%

影響市場成長的關鍵因素包括對女性健康意識的提高、微創測試和照護現場診斷等診斷程序的技術進步以及政府加強醫療基礎設施的支持政策。此外，慢性病盛行率的上升和對個人化醫療的需求不斷成長正在推動市場擴張。整合人工智慧和機器學習以提高診斷準確性，以及開發優先考慮便利性和隱私的家庭診斷工具也存在商機。企業應專注於擴大新興市場的准入，並與政策制定者合作，提高意識和負擔能力。

儘管存在這些充滿希望的機會，但仍存在一些挑戰，包括與先進診斷相關的高成本、監管障礙以及可能限制低收入地區市場滲透的醫療保健機會差異。此外，維護資料隱私和管理複雜的報銷系統是主要障礙。

我們可以透過開發具有成本效益的診斷解決方案和投資研究來增強疾病特異性生物感測器和生物標記來推進研究和開發。此外，利用遠端醫療服務涵蓋服務不足的人可以創造更廣泛的市場進入。綜觀市場格局，技術快速進步驅動的競爭格局，要求企業在研發投資上保持敏捷和進取。整體而言，女性健康診斷市場具有巨大的成長潛力，但要抓住這個市場需要將策略重點放在創新、可負擔性和可近性。

市場動態：快速發展的女性健康診斷市場的關鍵市場洞察

供需的動態交互作用正在改變女性健康診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 女性慢性病和文明病增加
    • 全球診斷成像中心數量增加
    • 改善且技術先進的醫療保健結構
  • 市場限制因素
    • 與手術和成像系統相關的高成本
  • 市場機會
    • 基於微流體和奈米技術的診斷 POC 設備受到高度關注
    • 有前途的數位科技趨勢塑造女性健康檢查
  • 市場挑戰
    • 技術熟練的醫療保健專業人員短缺

波特五力：駕馭女性健康診斷藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對女性健康診斷藥物市場的影響

外部宏觀環境因素對女性健康診斷藥物市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解女性健康診斷藥物市場競爭狀況

對女性健康診斷藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 女性健康診斷藥物市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估女性健康診斷市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃女性健康診斷藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對女性健康診斷藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 女性慢性病和文明病增加
      • 世界各地的診斷影像中心不斷增加
      • 改善且技術先進的醫療基礎設施
    • 抑制因素
      • 與手術和診斷成像系統相關的高成本
    • 機會
      • 專注於基於診斷微流體和奈米技術的 POC 設備
      • 有前景的數位科技趨勢塑造女性健康檢查
    • 任務
      • 技術熟練的醫療保健專業人員短缺
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 女性健康診斷藥物市場：依類型

  • 照護現場
  • 自檢

第7章 女性健康診斷藥物市場：依應用分類

  • 乳癌檢查
    • 切片檢查
    • 血液化學測試和血球計數測試
    • 腫瘤標記檢測
    • 乳房X光檢查
  • 子宮頸癌測試
    • HPV檢測
    • 子宮頸抹片
  • 傳染病檢查
    • 肝炎測試
    • 耐甲氧西林金黃色葡萄球菌測試
    • 結核病測試
    • 尿道感染測試（陰道pH值和陰道炎）
  • 骨質疏鬆測試
    • 骨骼密度測量
    • 體外血液檢查
  • 卵巢癌檢查
    • 診斷影像檢查
    • 卵巢癌腫瘤標記檢測
  • 妊娠及不孕症檢測
    • 妊娠監測儀
    • 基於實驗室的測試
    • 檢測套組和排卵預測套件
  • 產前基因篩檢和基因帶原檢測
    • 囊腫纖維化
    • 唐氏症和愛德華茲綜合症
    • 火炬感染疾病
  • 性行為感染傳染病檢測
    • 披衣菌感染衣原體和淋病 (CT/NG) 檢測
    • 愛滋病毒檢測
  • 超音波檢查
    • 乳房攝影診斷
    • 婦產科影像檢查診斷

第8章女性健康診斷藥物市場：依最終用戶分類

  • 診斷/影像診斷中心
  • 居家護理
  • 醫院/診所

第9章 北美和南美女性健康診斷藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太女性健康診斷藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲女性健康診斷藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerieux SA
  • Cardinal Health, Inc.
  • Carestream Health, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cook Medical, Inc.
  • Danaher Corporation
  • DIALAB GmbH
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Guided Therapeutics, Inc.
  • Hill-Rom Holdings, Inc.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • MedGyn Products, Inc.
  • NeuroLogica Corporation
  • Nova Biomedical
  • OSI Systems, Inc.
  • Perkinelmer Inc.
  • Quest Diagnostics Incorporated
  • Sekisui Diagnostics, LLC
  • Siemens AG
  • SuperSonic Imagine
  • Thermo Fisher Scientific Inc.
  • Werfen, SA
Product Code: MRR-43477954269C

The Women's Health Diagnostics Market was valued at USD 43.36 billion in 2023, expected to reach USD 46.82 billion in 2024, and is projected to grow at a CAGR of 9.25%, to USD 80.59 billion by 2030.

The Women's Health Diagnostics market is a pivotal segment within healthcare, focusing on diagnostic tools and techniques aimed at detecting and managing health conditions that uniquely or disproportionately affect women, such as breast cancer, osteoporosis, and reproductive health issues. The necessity for these diagnostics arises from the need for timely and accurate detection, which is crucial for effective treatment and management of such conditions. Applications include early-stage cancer detection, prenatal testing, fertility diagnostics, and monitoring of general well-being. The end-use scope covers hospitals, diagnostic laboratories, home care, and specialized clinics dedicated to women's health.

KEY MARKET STATISTICS
Base Year [2023] USD 43.36 billion
Estimated Year [2024] USD 46.82 billion
Forecast Year [2030] USD 80.59 billion
CAGR (%) 9.25%

Key factors influencing market growth include increasing awareness about women's health, technological advancements in diagnostic procedures like minimally invasive tests and point-of-care diagnostics, and supportive governmental policies enhancing healthcare infrastructure. Additionally, the rising prevalence of chronic diseases and growing demand for personalized medicine are fueling market expansion. Opportunities lie in the integration of AI and machine learning to refine diagnostic accuracy and the development of home-based diagnostic tools that prioritize convenience and privacy. Companies should focus on expanding access in emerging markets and collaborate with policy makers to enhance awareness and affordability.

Despite these promising opportunities, challenges include high costs associated with advanced diagnostics, regulatory hurdles, and disparities in healthcare access, which may limit market penetration in lower-income regions. Additionally, maintaining data privacy and navigating complex reimbursement landscapes pose significant obstacles.

Innovation can be driven by developing cost-effective diagnostic solutions and investing in research to enhance disease-specific biosensors and biomarkers. Furthermore, leveraging telehealth services to reach underserved populations can create broader market access. Insights on market nature indicate a competitive landscape with rapid technological advancements, requiring companies to remain agile and proactive in R&D investments. Overall, the Women's Health Diagnostics market holds substantial growth potential, but capturing it will require strategic focus on innovation, affordability, and accessibility.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Women's Health Diagnostics Market

The Women's Health Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incantaces of chronic and life-style related disorders in women
    • Rising number of imaging and diagnostic centres across the globe
    • Improved and technically advanced healthcare infastructure
  • Market Restraints
    • High cost associated with procedure and diagnostic imaging system
  • Market Opportunities
    • Substantial focus on microfluidics and nanotechnology-based POC devices for diagnostic
    • Promising digital technology trends shaping women's health diagnostic
  • Market Challenges
    • Dearth of technically skilled healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Women's Health Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Women's Health Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Women's Health Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Women's Health Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Women's Health Diagnostics Market

A detailed market share analysis in the Women's Health Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Women's Health Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Women's Health Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Women's Health Diagnostics Market

A strategic analysis of the Women's Health Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Women's Health Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux SA, Cardinal Health, Inc., Carestream Health, Inc., Chembio Diagnostic Systems, Inc., Cook Medical, Inc., Danaher Corporation, DIALAB GmbH, EKF Diagnostics Holdings PLC, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GE Healthcare, Guided Therapeutics, Inc., Hill-Rom Holdings, Inc., Hologic, Inc., Koninklijke Philips N.V., MedGyn Products, Inc., NeuroLogica Corporation, Nova Biomedical, OSI Systems, Inc., Perkinelmer Inc., Quest Diagnostics Incorporated, Sekisui Diagnostics, LLC, Siemens AG, SuperSonic Imagine, Thermo Fisher Scientific Inc., and Werfen, S.A..

Market Segmentation & Coverage

This research report categorizes the Women's Health Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Point-of-Care and Self Check.
  • Based on Application, market is studied across Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Ovarian Cancer Testing, Pregnancy & Fertility Testing, Prenatal Genetic Screening & Carrier Testing, Sexually Transmitted Disease Testing, and Ultrasound Tests. The Breast Cancer Testing is further studied across Biopsies, Blood Chemistries & Blood Cell Count Tests, Breast Cancer Tumor Marker Tests, and Mammography. The Cervical Cancer Testing is further studied across HPV Testing and PAP Smear. The Infectious Disease Testing is further studied across HEPAtitis Testing, MRSA Testing, Tuberculosis Testing, and Urinary Tract Infection Testing (Vaginal pH & Vaginitis). The Osteoporosis Testing is further studied across Bone Densitometry and in Vitro Blood Tests. The Ovarian Cancer Testing is further studied across Diagnostic Imaging Tests and Ovarian Cancer Tumor Marker Tests. The Pregnancy & Fertility Testing is further studied across Fertility Monitors, Lab-Based Testing, and Pregnancy Testing & Ovulation Prediction Kits. The Prenatal Genetic Screening & Carrier Testing is further studied across Cystic Fibrosis, Down Syndrome & Edwards Syndrome, and Torch Infections. The Sexually Transmitted Disease Testing is further studied across Chlamydia Trachomatis & Neisseria Gonorrhoeae (CT/NG) Testing and HIV Testing. The Ultrasound Tests is further studied across Breast Imaging and OB/GYN Imaging.
  • Based on End-User, market is studied across Diagnostic & Imaging Centers, Home Care, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incantaces of chronic and life-style related disorders in women
      • 5.1.1.2. Rising number of imaging and diagnostic centres across the globe
      • 5.1.1.3. Improved and technically advanced healthcare infastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with procedure and diagnostic imaging system
    • 5.1.3. Opportunities
      • 5.1.3.1. Substantial focus on microfluidics and nanotechnology-based POC devices for diagnostic
      • 5.1.3.2. Promising digital technology trends shaping women's health diagnostic
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of technically skilled healthcare professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Women's Health Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Point-of-Care
  • 6.3. Self Check

7. Women's Health Diagnostics Market, by Application

  • 7.1. Introduction
  • 7.2. Breast Cancer Testing
    • 7.2.1. Biopsies
    • 7.2.2. Blood Chemistries & Blood Cell Count Tests
    • 7.2.3. Breast Cancer Tumor Marker Tests
    • 7.2.4. Mammography
  • 7.3. Cervical Cancer Testing
    • 7.3.1. HPV Testing
    • 7.3.2. PAP Smear
  • 7.4. Infectious Disease Testing
    • 7.4.1. HEPAtitis Testing
    • 7.4.2. MRSA Testing
    • 7.4.3. Tuberculosis Testing
    • 7.4.4. Urinary Tract Infection Testing (Vaginal pH & Vaginitis)
  • 7.5. Osteoporosis Testing
    • 7.5.1. Bone Densitometry
    • 7.5.2. in Vitro Blood Tests
  • 7.6. Ovarian Cancer Testing
    • 7.6.1. Diagnostic Imaging Tests
    • 7.6.2. Ovarian Cancer Tumor Marker Tests
  • 7.7. Pregnancy & Fertility Testing
    • 7.7.1. Fertility Monitors
    • 7.7.2. Lab-Based Testing
    • 7.7.3. Pregnancy Testing & Ovulation Prediction Kits
  • 7.8. Prenatal Genetic Screening & Carrier Testing
    • 7.8.1. Cystic Fibrosis
    • 7.8.2. Down Syndrome & Edwards Syndrome
    • 7.8.3. Torch Infections
  • 7.9. Sexually Transmitted Disease Testing
    • 7.9.1. Chlamydia Trachomatis & Neisseria Gonorrhoeae (CT/NG) Testing
    • 7.9.2. HIV Testing
  • 7.10. Ultrasound Tests
    • 7.10.1. Breast Imaging
    • 7.10.2. OB/GYN Imaging

8. Women's Health Diagnostics Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic & Imaging Centers
  • 8.3. Home Care
  • 8.4. Hospitals & Clinics

9. Americas Women's Health Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Women's Health Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Women's Health Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AccuBioTech Co., Ltd.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomerieux SA
  • 6. Cardinal Health, Inc.
  • 7. Carestream Health, Inc.
  • 8. Chembio Diagnostic Systems, Inc.
  • 9. Cook Medical, Inc.
  • 10. Danaher Corporation
  • 11. DIALAB GmbH
  • 12. EKF Diagnostics Holdings PLC
  • 13. F. Hoffmann-La Roche Ltd.
  • 14. FUJIFILM Holdings Corporation
  • 15. GE Healthcare
  • 16. Guided Therapeutics, Inc.
  • 17. Hill-Rom Holdings, Inc.
  • 18. Hologic, Inc.
  • 19. Koninklijke Philips N.V.
  • 20. MedGyn Products, Inc.
  • 21. NeuroLogica Corporation
  • 22. Nova Biomedical
  • 23. OSI Systems, Inc.
  • 24. Perkinelmer Inc.
  • 25. Quest Diagnostics Incorporated
  • 26. Sekisui Diagnostics, LLC
  • 27. Siemens AG
  • 28. SuperSonic Imagine
  • 29. Thermo Fisher Scientific Inc.
  • 30. Werfen, S.A.

LIST OF FIGURES

  • FIGURE 1. WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. WOMEN'S HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. WOMEN'S HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WOMEN'S HEALTH DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES & BLOOD CELL COUNT TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING & OVULATION PREDICTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME & EDWARDS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 203. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 214. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 215. MALAYSIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 226. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 235. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 236. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 238. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 239. SINGAPORE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 258. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 259. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 260. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 261. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 262. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 263. TAIWAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 270. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 271. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 272. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 273. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 274. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 275. THAILAND WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 282. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 283. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 284. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
  • TABLE 285. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 286. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
  • TABLE 287. VIETNAM WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & F